DRUG · Unmapped registry intervention
TN
Find medicine records ·
Find other trials using this name
Clinical trial
Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
NCT06535893
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
TN-1
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Sponsors & collaborators
Nagoya City Universitylead sponsor
Japan Clinical Oncology Groupcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06535893 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.